| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 2.75e-05 | 8 | 160 | 3 | GO:0140945 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 5.81e-05 | 10 | 160 | 3 | GO:0140999 | |
| GeneOntologyMolecularFunction | chromatin binding | FOXO1 POLR1A EP400 CHD8 CHD7 SMARCAD1 ONECUT1 CREBBP HDAC7 PHC2 JARID2 ATXN7 TP63 TLE4 SKOR2 CUX1 HR | 9.41e-05 | 739 | 160 | 17 | GO:0003682 |
| GeneOntologyMolecularFunction | polyamine oxidase activity | 1.90e-04 | 3 | 160 | 2 | GO:0046592 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.13e-04 | 37 | 160 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor | 3.79e-04 | 4 | 160 | 2 | GO:0016647 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 4.20e-04 | 44 | 160 | 4 | GO:0140938 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 5.21e-04 | 20 | 160 | 3 | GO:0042800 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RANGAP1 KMT2B POLR1A WWOX AFF2 EP400 NUP210L BICRA CHD8 MIDEAS ADAR CREBBP HDAC7 PHC2 EFTUD2 PCF11 JARID2 KMT2C KMT2D R3HCC1L ATXN7 TLE4 CPSF1 BICRAL SAP130 HR | 1.52e-05 | 1377 | 159 | 26 | GO:0140513 |
| GeneOntologyCellularComponent | histone methyltransferase complex | 2.69e-04 | 75 | 159 | 5 | GO:0035097 | |
| GeneOntologyCellularComponent | nuclear speck | AFF2 EP400 ADAMTS4 BMP2K RADX SRY UBASH3A ADAR EFTUD2 SAP130 MAML3 | 4.75e-04 | 431 | 159 | 11 | GO:0016607 |
| GeneOntologyCellularComponent | histone deacetylase complex | 4.80e-04 | 85 | 159 | 5 | GO:0000118 | |
| HumanPheno | Bilateral choanal atresia | 3.51e-08 | 9 | 65 | 5 | HP:0004502 | |
| HumanPheno | Abnormal earlobe morphology | HIVEP2 KMT2B WWOX BICRA CHD7 CREBBP EFTUD2 KMT2C KMT2D SEC24C FGD1 PHIP | 1.05e-07 | 137 | 65 | 12 | HP:0000363 |
| HumanPheno | Epicanthus | HSPG2 FAT4 KMT2B POLR1A WWOX AFF2 ANK1 BICRA CHD8 SRY CHD7 RFX7 CREBBP PREPL EFTUD2 JARID2 KMT2D SEC24C DCHS1 FGD1 FGFR3 CTNND2 GDF11 PHIP | 1.84e-07 | 614 | 65 | 24 | HP:0000286 |
| HumanPheno | Abnormality of the outer ear | HSPG2 FAT4 HIVEP2 KMT2B POLR1A WWOX AFF2 ANK1 BICRA GRB10 ESAM CRPPA CHD8 SRY CHD7 SIM1 RFX7 ADAR CREBBP PREPL EFTUD2 JARID2 KMT2C KMT2D SEC24C CLCNKA TP63 DCHS1 FGD1 CC2D2A FGFR3 PLEC CTNND2 GDF11 PHIP CUX1 | 5.14e-07 | 1337 | 65 | 36 | HP:0000356 |
| HumanPheno | Microtia | HSPG2 FAT4 HIVEP2 POLR1A CRPPA CHD7 SIM1 EFTUD2 KMT2D TP63 DCHS1 FGFR3 PLEC | 7.23e-07 | 195 | 65 | 13 | HP:0008551 |
| HumanPheno | Abnormality of the larynx | HSPG2 COL12A1 TRIM2 KMT2B POLR1A WWOX AFF2 LAMA3 GRB10 CRPPA CHD7 SIM1 RFX7 ADAR CREBBP PREPL SIL1 KMT2D SEC24C TP63 FGFR3 PLEC CTNND2 PHIP | 8.51e-07 | 666 | 65 | 24 | HP:0001600 |
| HumanPheno | Abnormal pinna morphology | HSPG2 FAT4 HIVEP2 KMT2B POLR1A WWOX AFF2 ANK1 BICRA ESAM CRPPA CHD8 SRY CHD7 SIM1 RFX7 ADAR CREBBP PREPL EFTUD2 JARID2 KMT2C KMT2D SEC24C CLCNKA TP63 DCHS1 FGD1 CC2D2A FGFR3 PLEC CTNND2 GDF11 PHIP CUX1 | 8.68e-07 | 1299 | 65 | 35 | HP:0000377 |
| HumanPheno | Aplasia/Hypoplasia of the external ear | HSPG2 FAT4 HIVEP2 POLR1A CRPPA CHD7 SIM1 EFTUD2 KMT2D TP63 DCHS1 FGFR3 PLEC | 1.69e-06 | 210 | 65 | 13 | HP:0008772 |
| HumanPheno | Abnormal midface morphology | HSPG2 FAT4 KMT2B POLR1A ANK1 BICRA ESAM CHD7 SIM1 RFX7 CREBBP EFTUD2 JARID2 LINS1 KMT2C KMT2D SEC24C TP63 DCHS1 FGD1 CC2D2A FGFR3 CTNND2 GDF11 | 2.36e-06 | 704 | 65 | 24 | HP:0000309 |
| HumanPheno | Aplasia/Hypoplasia of the ear | HSPG2 FAT4 HIVEP2 POLR1A CRPPA CHD7 SIM1 EFTUD2 KMT2D TP63 DCHS1 FGFR3 PLEC | 2.71e-06 | 219 | 65 | 13 | HP:0008771 |
| HumanPheno | Abnormality of the jaws | HSPG2 FAT4 COL12A1 KMT2B POLR1A WWOX ANK1 BICRA GRB10 ESAM CRPPA CHD8 SRY CHD7 SIM1 RFX7 ATP10A CREBBP PREPL EFTUD2 JARID2 KMT2D SEC24C TP63 DCHS1 FGD1 CC2D2A FGFR3 CTNND2 GDF11 PHIP TBX5 | 3.13e-06 | 1175 | 65 | 32 | HP:0000209 |
| HumanPheno | Abnormal jaw morphology | HSPG2 FAT4 COL12A1 KMT2B POLR1A WWOX ANK1 BICRA GRB10 ESAM CRPPA CHD8 SRY CHD7 SIM1 RFX7 ATP10A CREBBP PREPL EFTUD2 JARID2 KMT2D SEC24C TP63 DCHS1 FGD1 CC2D2A FGFR3 CTNND2 GDF11 PHIP TBX5 | 3.20e-06 | 1176 | 65 | 32 | HP:0030791 |
| HumanPheno | Abnormal mandible morphology | HSPG2 FAT4 COL12A1 KMT2B POLR1A WWOX ANK1 BICRA GRB10 ESAM CRPPA CHD8 SRY CHD7 SIM1 RFX7 ATP10A CREBBP PREPL EFTUD2 JARID2 KMT2D SEC24C DCHS1 FGD1 CC2D2A FGFR3 CTNND2 GDF11 PHIP TBX5 | 3.44e-06 | 1118 | 65 | 31 | HP:0000277 |
| HumanPheno | Abnormal calvaria morphology | HSPG2 FAT4 HIVEP2 KMT2B POLR1A WWOX BICRA GRB10 TCIRG1 ESAM CRPPA SIM1 RFX7 ADAR CREBBP PREPL PLEKHM1 EFTUD2 PHEX JARID2 KMT2C KMT2D SEC24C TP63 DCHS1 FGD1 CC2D2A FGFR3 PLEC GDF11 PHIP CUX1 TBX5 | 4.27e-06 | 1254 | 65 | 33 | HP:0002683 |
| HumanPheno | Abnormality of calvarial morphology | HSPG2 FAT4 HIVEP2 KMT2B POLR1A WWOX BICRA GRB10 TCIRG1 ESAM CRPPA SIM1 RFX7 ADAR CREBBP PREPL EFTUD2 PHEX JARID2 KMT2C KMT2D SEC24C TP63 FGD1 CC2D2A FGFR3 PLEC GDF11 PHIP CUX1 TBX5 | 4.71e-06 | 1134 | 65 | 31 | HP:0002648 |
| HumanPheno | Abnormal thorax morphology | HSPG2 FAT4 COL12A1 HIVEP2 POLR1A WWOX ANK1 BICRA TCIRG1 ESAM CRPPA SRY CHD7 SIM1 RFX7 CREBBP PLEKHM1 SIL1 PHEX KMT2C KMT2D SEC24C TP63 TRIM8 DCHS1 FGD1 CC2D2A FGFR3 CTNND2 GDF11 CUX1 SEC23B GAA TBX5 | 5.09e-06 | 1328 | 65 | 34 | HP:0000765 |
| HumanPheno | Abnormal eyelid morphology | HSPG2 FAT4 HIVEP2 KMT2B POLR1A WWOX AFF2 ANK1 BICRA LAMA3 ESAM CHD8 SRY CHD7 SIM1 RFX7 ADAR CREBBP PREPL EFTUD2 JARID2 KMT2C KMT2D SEC24C TP63 DCHS1 FGD1 FGFR3 PLEC CTNND2 GDF11 PHIP CUX1 PCSK9 HR | 6.56e-06 | 1408 | 65 | 35 | HP:0000492 |
| HumanPheno | Abnormal cheek morphology | HSPG2 FAT4 KMT2B ANK1 BICRA ESAM CHD7 SIM1 CREBBP EFTUD2 KMT2D FGD1 CC2D2A CTNND2 | 8.69e-06 | 282 | 65 | 14 | HP:0004426 |
| HumanPheno | Abnormality of the upper respiratory tract | HSPG2 FAT4 COL12A1 TRIM2 KMT2B POLR1A WWOX AFF2 LAMA3 GRB10 TCIRG1 ESAM CRPPA CHD7 SIM1 RFX7 ADAR CREBBP PREPL SIL1 KMT2C KMT2D SEC24C TP63 DCHS1 FGFR3 PLEC LRBA CTNND2 PHIP | 9.90e-06 | 1111 | 65 | 30 | HP:0002087 |
| HumanPheno | Syndactyly | FAT4 KMT2B BICRA LAMA3 GRB10 SMARCAD1 RFX7 CREBBP JARID2 TP63 DCHS1 FGD1 FGFR3 PLEC CTNND2 PHIP TBX5 | 1.13e-05 | 417 | 65 | 17 | HP:0001159 |
| HumanPheno | Localized skin lesion | HSPG2 FAT4 COL12A1 POLR1A ANK1 LAMA3 GRB10 TCIRG1 CHD7 SMARCAD1 RFX7 ADAR CREBBP EFTUD2 KMT2D SEC24C TP63 DCHS1 FGD1 FGFR3 PLEC CTNND2 PHIP SEC23B PCSK9 TBX5 | 1.60e-05 | 897 | 65 | 26 | HP:0011355 |
| HumanPheno | Abnormal palate morphology | HSPG2 FAT4 COL12A1 HIVEP2 KMT2B POLR1A ANK1 BICRA GRB10 ESAM CRPPA SRY CHD7 RFX7 CREBBP EFTUD2 JARID2 KMT2C KMT2D SEC24C TP63 TRIM8 DCHS1 FGD1 CC2D2A FGFR3 CTNND2 GDF11 PHIP SEC23B TBX5 | 1.68e-05 | 1202 | 65 | 31 | HP:0000174 |
| HumanPheno | Motor delay | COL12A1 TRIM2 HIVEP2 KMT2B POLR1A WWOX SPTBN2 GRB10 ESAM CRPPA CHD8 CHD7 SIM1 RFX7 ATP10A CREBBP PREPL PHEX LINS1 KMT2C KMT2D CLCNKA ATXN7 TRIM8 FGFR3 PLEC CUX1 GAA | 1.71e-05 | 1018 | 65 | 28 | HP:0001270 |
| HumanPheno | Micrognathia | HSPG2 FAT4 COL12A1 POLR1A WWOX ANK1 BICRA GRB10 ESAM CHD8 SRY CHD7 SIM1 CREBBP EFTUD2 KMT2D SEC24C DCHS1 FGD1 CC2D2A FGFR3 CTNND2 GDF11 PHIP TBX5 | 1.71e-05 | 843 | 65 | 25 | HP:0000347 |
| HumanPheno | Aplasia/Hypoplasia of the mandible | HSPG2 FAT4 COL12A1 POLR1A WWOX ANK1 BICRA GRB10 ESAM CHD8 SRY CHD7 SIM1 CREBBP EFTUD2 KMT2D SEC24C DCHS1 FGD1 CC2D2A FGFR3 CTNND2 GDF11 PHIP TBX5 | 1.78e-05 | 845 | 65 | 25 | HP:0009118 |
| HumanPheno | Frontal bossing | HSPG2 FAT4 HIVEP2 KMT2B POLR1A WWOX BICRA GRB10 TCIRG1 ESAM CRPPA SIM1 RFX7 CREBBP PREPL PHEX JARID2 KMT2D TP63 FGD1 FGFR3 PHIP CUX1 | 1.95e-05 | 738 | 65 | 23 | HP:0002007 |
| HumanPheno | Abnormal shape of the frontal region | HSPG2 FAT4 HIVEP2 KMT2B POLR1A WWOX BICRA GRB10 TCIRG1 ESAM CRPPA SIM1 RFX7 CREBBP PREPL PHEX JARID2 KMT2D TP63 FGD1 FGFR3 PHIP CUX1 | 2.09e-05 | 741 | 65 | 23 | HP:0011218 |
| HumanPheno | Choanal atresia | 2.13e-05 | 123 | 65 | 9 | HP:0000453 | |
| HumanPheno | Abnormal frontal bone morphology | HSPG2 FAT4 HIVEP2 KMT2B POLR1A WWOX BICRA GRB10 TCIRG1 ESAM CRPPA SIM1 RFX7 CREBBP PREPL PHEX JARID2 KMT2D TP63 FGD1 FGFR3 PHIP CUX1 | 2.14e-05 | 742 | 65 | 23 | HP:0430000 |
| HumanPheno | Dental malocclusion | HSPG2 FAT4 TCIRG1 CREBBP PLEKHM1 KMT2D TP63 DCHS1 FGD1 FGFR3 | 2.28e-05 | 156 | 65 | 10 | HP:0000689 |
| HumanPheno | Aplasia/Hypoplasia involving bones of the skull | HSPG2 FAT4 COL12A1 POLR1A WWOX ANK1 BICRA GRB10 ESAM CHD8 SRY CHD7 SIM1 CREBBP EFTUD2 KMT2D SEC24C TP63 DCHS1 FGD1 CC2D2A FGFR3 CTNND2 GDF11 PHIP TBX5 | 2.30e-05 | 915 | 65 | 26 | HP:0009116 |
| HumanPheno | Abnormality of the voice | HSPG2 TRIM2 KMT2B POLR1A WWOX AFF2 LAMA3 GRB10 CRPPA CHD7 SIM1 ADAR PREPL SIL1 KMT2D SEC24C TP63 PLEC CTNND2 | 2.89e-05 | 545 | 65 | 19 | HP:0001608 |
| HumanPheno | Tracheomalacia | 3.11e-05 | 49 | 65 | 6 | HP:0002779 | |
| HumanPheno | Abnormal external genitalia | HSPG2 FAT4 POLR1A WWOX ANK1 BICRA LAMA3 GRB10 ESAM CRPPA SRY CHD7 MSH5 SIM1 RFX7 ADAR CREBBP SIL1 KMT2C KMT2D SEC24C TP63 TRIM8 DCHS1 FGD1 CC2D2A FGFR3 PLEC CTNND2 GDF11 PHIP CUX1 SEC23B | 3.33e-05 | 1372 | 65 | 33 | HP:0000811 |
| HumanPheno | Abnormality of the palpebral fissures | HSPG2 FAT4 HIVEP2 POLR1A WWOX ANK1 BICRA ESAM CHD8 CHD7 SIM1 RFX7 CREBBP EFTUD2 JARID2 KMT2C KMT2D SEC24C TP63 DCHS1 FGD1 FGFR3 CTNND2 PHIP CUX1 | 3.65e-05 | 880 | 65 | 25 | HP:0008050 |
| HumanPheno | Abnormal larynx morphology | HSPG2 COL12A1 TRIM2 POLR1A LAMA3 CHD7 RFX7 CREBBP SEC24C FGFR3 PHIP | 3.78e-05 | 201 | 65 | 11 | HP:0025423 |
| HumanPheno | Abnormal finger morphology | HSPG2 FAT4 COL12A1 HIVEP2 KMT2B POLR1A AFF2 BICRA LAMA3 GRB10 ESAM CRPPA CHD7 SMARCAD1 SIM1 RFX7 ADAR CREBBP SIL1 EFTUD2 JARID2 KMT2C KMT2D SEC24C TP63 TRIM8 FGD1 CC2D2A FGFR3 PLEC LRBA PHIP TBX5 | 4.11e-05 | 1385 | 65 | 33 | HP:0001167 |
| HumanPheno | Cutaneous syndactyly | 4.14e-05 | 103 | 65 | 8 | HP:0012725 | |
| HumanPheno | Choanal atresia or stenosis | 4.23e-05 | 134 | 65 | 9 | HP:0000416 | |
| HumanPheno | Abnormal choanae morphology | 4.23e-05 | 134 | 65 | 9 | HP:0000415 | |
| HumanPheno | Aplasia/hypoplasia affecting bones of the axial skeleton | HSPG2 FAT4 COL12A1 POLR1A WWOX ANK1 BICRA GRB10 TCIRG1 ESAM CHD8 SRY CHD7 SIM1 CREBBP EFTUD2 KMT2D SEC24C TP63 DCHS1 FGD1 CC2D2A FGFR3 CTNND2 GDF11 PHIP TBX5 | 4.39e-05 | 1008 | 65 | 27 | HP:0009122 |
| HumanPheno | Abnormality of the urethra | HSPG2 FAT4 WWOX BICRA LAMA3 GRB10 SRY CREBBP KMT2D SEC24C TP63 TRIM8 DCHS1 FGD1 CC2D2A PLEC CUX1 | 4.72e-05 | 465 | 65 | 17 | HP:0000795 |
| HumanPheno | Abnormal male external genitalia morphology | HSPG2 FAT4 POLR1A WWOX ANK1 BICRA LAMA3 GRB10 ESAM CRPPA SRY CHD7 MSH5 SIM1 RFX7 ADAR CREBBP KMT2C KMT2D SEC24C TP63 TRIM8 DCHS1 FGD1 CC2D2A FGFR3 PLEC CTNND2 GDF11 PHIP CUX1 SEC23B | 4.83e-05 | 1329 | 65 | 32 | HP:0000032 |
| HumanPheno | Delayed ability to stand | 5.07e-05 | 17 | 65 | 4 | HP:0025335 | |
| HumanPheno | Microcephaly | HSPG2 FAT4 FOXRED1 HIVEP2 KMT2B POLR1A WWOX AFF2 ANK1 BICRA ESAM CRPPA CHD8 CHD7 PLEKHG2 RFX7 ADAR ATP10A CREBBP SIL1 EFTUD2 JARID2 LINS1 KMT2C KMT2D SEC24C TRIM8 DCHS1 FGD1 CC2D2A FGFR3 CTNND2 | 5.85e-05 | 1341 | 65 | 32 | HP:0000252 |
| HumanPheno | Midface retrusion | HSPG2 FAT4 POLR1A BICRA EFTUD2 JARID2 LINS1 KMT2C KMT2D DCHS1 FGD1 FGFR3 GDF11 | 5.88e-05 | 291 | 65 | 13 | HP:0011800 |
| HumanPheno | Anal stenosis | 6.05e-05 | 34 | 65 | 5 | HP:0002025 | |
| HumanPheno | Overfolded helix | 7.09e-05 | 82 | 65 | 7 | HP:0000396 | |
| HumanPheno | Decreased head circumference | HSPG2 FAT4 FOXRED1 HIVEP2 KMT2B POLR1A WWOX AFF2 ANK1 BICRA ESAM CRPPA CHD8 CHD7 PLEKHG2 RFX7 ADAR ATP10A CREBBP SIL1 EFTUD2 JARID2 LINS1 KMT2C KMT2D SEC24C TRIM8 DCHS1 FGD1 CC2D2A FGFR3 CTNND2 | 7.18e-05 | 1354 | 65 | 32 | HP:0040195 |
| HumanPheno | Abnormal upper lip morphology | HSPG2 FAT4 HIVEP2 POLR1A WWOX AFF2 ESAM CHD8 CHD7 SIM1 RFX7 CREBBP PREPL EFTUD2 JARID2 KMT2D SEC24C TP63 TRIM8 DCHS1 FGD1 CC2D2A GDF11 PHIP CUX1 TBX5 | 7.90e-05 | 980 | 65 | 26 | HP:0000177 |
| HumanPheno | Feeding difficulties | HSPG2 FAT4 FOXRED1 HIVEP2 KMT2B POLR1A WWOX ANK1 BICRA GRB10 ESAM CHD8 CHD7 SIM1 ADAR ATP10A CREBBP PREPL EFTUD2 KMT2D SEC24C CLCNKA ATXN7 TP63 DCHS1 CC2D2A FGFR3 PHIP GAA | 8.23e-05 | 1168 | 65 | 29 | HP:0011968 |
| HumanPheno | Laryngomalacia | 8.28e-05 | 84 | 65 | 7 | HP:0001601 | |
| HumanPheno | Abnormality of the helix | HSPG2 AFF2 BICRA CHD7 CREBBP EFTUD2 KMT2D SEC24C FGFR3 GDF11 | 8.99e-05 | 183 | 65 | 10 | HP:0000380 |
| HumanPheno | Large earlobe | 9.21e-05 | 37 | 65 | 5 | HP:0009748 | |
| HumanPheno | Macrocephaly | HSPG2 POLR1A AFF2 BICRA GRB10 TCIRG1 CRPPA CHD8 SIM1 RFX7 JARID2 KMT2C FGD1 CC2D2A FGFR3 PLEC SEC23B | 9.40e-05 | 491 | 65 | 17 | HP:0000256 |
| HumanPheno | Hypocalcemia | 9.63e-05 | 86 | 65 | 7 | HP:0002901 | |
| HumanPheno | Increased head circumference | HSPG2 POLR1A AFF2 BICRA GRB10 TCIRG1 CRPPA CHD8 SIM1 RFX7 JARID2 KMT2C FGD1 CC2D2A FGFR3 PLEC SEC23B | 1.18e-04 | 500 | 65 | 17 | HP:0040194 |
| HumanPheno | Abnormally folded helix | 1.29e-04 | 90 | 65 | 7 | HP:0008544 | |
| HumanPheno | Joint hypermobility | FAT4 COL12A1 POLR1A BICRA ESAM CHD7 RFX7 CREBBP JARID2 KMT2D SEC24C TRIM8 DCHS1 FGD1 FGFR3 CTNND2 GDF11 PHIP | 1.36e-04 | 557 | 65 | 18 | HP:0001382 |
| HumanPheno | Hyperactivity | HSPG2 HIVEP2 KMT2B WWOX AFF2 CHD8 CHD7 SIM1 RFX7 ATP10A CREBBP JARID2 SEC24C TRIM8 FGD1 CACNA1H FGFR3 PHIP | 1.39e-04 | 558 | 65 | 18 | HP:0000752 |
| HumanPheno | Macule | HSPG2 SMARCAD1 RFX7 ADAR CREBBP KMT2D TP63 FGFR3 PLEC PHIP SEC23B | 1.51e-04 | 234 | 65 | 11 | HP:0012733 |
| HumanPheno | Generalized osteosclerosis | 1.58e-04 | 9 | 65 | 3 | HP:0005789 | |
| HumanPheno | Abnormal hand morphology | HSPG2 FAT4 KMT2B POLR1A WWOX AFF2 BICRA LAMA3 GRB10 SRY CHD7 SIM1 CREBBP SIL1 EFTUD2 PHEX KMT2D SEC24C TP63 TRIM8 DCHS1 FGD1 CC2D2A FGFR3 CTNND2 PHIP TBX5 | 1.59e-04 | 1082 | 65 | 27 | HP:0005922 |
| HumanPheno | Abnormal metatarsal morphology | 1.60e-04 | 159 | 65 | 9 | HP:0001832 | |
| HumanPheno | Autistic behavior | HSPG2 FOXRED1 HIVEP2 KMT2B WWOX AFF2 BICRA CHD8 SRY CHD7 SIM1 RFX7 CREBBP JARID2 KMT2C KMT2D SEC24C TRIM8 CC2D2A SEC23B | 1.84e-04 | 678 | 65 | 20 | HP:0000729 |
| HumanPheno | Abnormal hair morphology | HSPG2 FAT4 HIVEP2 KMT2B POLR1A WWOX BICRA LAMA3 TCIRG1 ESAM CHD8 SRY CHD7 SIM1 ADAR ATP10A CREBBP PREPL JARID2 KMT2C KMT2D SEC24C TP63 TRIM8 FGD1 CC2D2A FGFR3 PLEC GDF11 PHIP SEC23B HR | 2.04e-04 | 1424 | 65 | 32 | HP:0001595 |
| HumanPheno | Abnormal external nose morphology | HSPG2 HIVEP2 KMT2B POLR1A WWOX BICRA ESAM SIM1 RFX7 ADAR CREBBP EFTUD2 JARID2 KMT2D SEC24C TP63 TRIM8 FGD1 CC2D2A FGFR3 PLEC GDF11 PHIP CUX1 | 2.13e-04 | 916 | 65 | 24 | HP:0010938 |
| HumanPheno | Hypoplasia of the maxilla | 2.15e-04 | 130 | 65 | 8 | HP:0000327 | |
| HumanPheno | Hypospadias | HSPG2 FAT4 WWOX BICRA GRB10 SRY CREBBP KMT2D SEC24C TP63 TRIM8 DCHS1 FGD1 CUX1 | 2.17e-04 | 377 | 65 | 14 | HP:0000047 |
| HumanPheno | Upslanted palpebral fissure | HIVEP2 POLR1A WWOX ANK1 BICRA ESAM SIM1 RFX7 CREBBP EFTUD2 JARID2 SEC24C PHIP | 2.32e-04 | 333 | 65 | 13 | HP:0000582 |
| HumanPheno | Diagnostic behavioral phenotype | WHRN HSPG2 FOXRED1 HIVEP2 KMT2B WWOX AFF2 BICRA CHD8 SRY CHD7 SIM1 RFX7 CREBBP JARID2 KMT2C KMT2D SEC24C TRIM8 CC2D2A SEC23B | 2.38e-04 | 747 | 65 | 21 | HP:0025783 |
| HumanPheno | Abnormality of the male genitalia | HSPG2 FAT4 POLR1A WWOX ANK1 BICRA LAMA3 GRB10 ESAM CRPPA SRY CHD7 MSH5 SIM1 RFX7 ADAR CREBBP KMT2C KMT2D SEC24C TP63 TRIM8 DCHS1 FGD1 CC2D2A FGFR3 PLEC CTNND2 GDF11 PHIP CUX1 SEC23B | 2.45e-04 | 1437 | 65 | 32 | HP:0010461 |
| HumanPheno | Disinhibition | HSPG2 FAT4 HIVEP2 KMT2B WWOX AFF2 CHD8 CHD7 SIM1 RFX7 ATP10A CREBBP JARID2 LINS1 KMT2C SEC24C TRIM8 DCHS1 FGD1 CACNA1H FGFR3 PHIP | 2.50e-04 | 807 | 65 | 22 | HP:0000734 |
| HumanPheno | Inappropriate behavior | HSPG2 FAT4 HIVEP2 KMT2B WWOX AFF2 CHD8 CHD7 SIM1 RFX7 ATP10A CREBBP JARID2 LINS1 KMT2C SEC24C TRIM8 DCHS1 FGD1 CACNA1H FGFR3 PHIP | 2.50e-04 | 807 | 65 | 22 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | HSPG2 FAT4 HIVEP2 KMT2B WWOX AFF2 CHD8 CHD7 SIM1 RFX7 ATP10A CREBBP JARID2 LINS1 KMT2C SEC24C TRIM8 DCHS1 FGD1 CACNA1H FGFR3 PHIP | 2.50e-04 | 807 | 65 | 22 | HP:5200123 |
| HumanPheno | Social disinhibition | HSPG2 FAT4 HIVEP2 KMT2B WWOX AFF2 CHD8 CHD7 SIM1 RFX7 ATP10A CREBBP JARID2 LINS1 KMT2C SEC24C TRIM8 DCHS1 FGD1 CACNA1H FGFR3 PHIP | 2.50e-04 | 807 | 65 | 22 | HP:5200029 |
| HumanPheno | Aplasia/Hypoplasia of the maxilla | 2.52e-04 | 133 | 65 | 8 | HP:0009117 | |
| HumanPheno | Abnormally increased volition | HSPG2 FAT4 HIVEP2 KMT2B WWOX AFF2 CHD8 CHD7 SIM1 RFX7 ATP10A CREBBP JARID2 LINS1 KMT2C SEC24C ATXN7 TRIM8 DCHS1 FGD1 CACNA1H FGFR3 PHIP | 2.65e-04 | 869 | 65 | 23 | HP:5200263 |
| HumanPheno | Ptosis | HSPG2 FAT4 FOXRED1 KMT2B POLR1A WWOX CHD8 CHD7 ADAR CREBBP PREPL JARID2 KMT2D SEC24C TP63 DCHS1 FGD1 CC2D2A FGFR3 PLEC PHIP | 2.72e-04 | 754 | 65 | 21 | HP:0000508 |
| HumanPheno | Cleft palate | HSPG2 POLR1A BICRA CRPPA CHD7 RFX7 CREBBP EFTUD2 JARID2 KMT2C KMT2D SEC24C TP63 TRIM8 FGD1 CC2D2A FGFR3 GDF11 TBX5 | 2.77e-04 | 643 | 65 | 19 | HP:0000175 |
| HumanPheno | Abnormal hard palate morphology | HSPG2 POLR1A BICRA CRPPA CHD7 RFX7 CREBBP EFTUD2 JARID2 KMT2C KMT2D SEC24C TP63 TRIM8 FGD1 CC2D2A FGFR3 GDF11 TBX5 | 3.00e-04 | 647 | 65 | 19 | HP:0100737 |
| HumanPheno | Abnormal helix morphology | HSPG2 AFF2 BICRA CHD7 CREBBP EFTUD2 KMT2D SEC24C FGFR3 GDF11 | 3.03e-04 | 212 | 65 | 10 | HP:0011039 |
| HumanPheno | Feeding difficulties in infancy | HSPG2 FAT4 POLR1A WWOX GRB10 CHD8 CHD7 SIM1 ATP10A CREBBP EFTUD2 KMT2D SEC24C TP63 DCHS1 CC2D2A PHIP GAA | 3.09e-04 | 594 | 65 | 18 | HP:0008872 |
| HumanPheno | Carious teeth | 3.16e-04 | 174 | 65 | 9 | HP:0000670 | |
| HumanPheno | Failure to thrive | HSPG2 FOXRED1 COL12A1 HIVEP2 POLR1A WWOX BICRA LAMA3 GRB10 TCIRG1 CHD7 SIM1 ADAR CREBBP PREPL SIL1 LINS1 KMT2C KMT2D SEC24C CLCNKA ATXN7 TRIM8 FGD1 LRBA SEC23B GAA | 3.28e-04 | 1128 | 65 | 27 | HP:0001508 |
| HumanPheno | Abnormal location of ears | HSPG2 FAT4 KMT2B POLR1A BICRA ESAM CRPPA CHD8 SRY CHD7 SIM1 RFX7 ADAR CREBBP PREPL EFTUD2 JARID2 KMT2D SEC24C FGD1 CC2D2A FGFR3 CTNND2 CUX1 | 3.48e-04 | 945 | 65 | 24 | HP:0000357 |
| HumanPheno | Abnormal penis morphology | HSPG2 FAT4 WWOX ANK1 BICRA GRB10 CRPPA SRY CHD7 SIM1 ADAR CREBBP KMT2D SEC24C TP63 TRIM8 DCHS1 FGD1 CUX1 SEC23B | 3.60e-04 | 712 | 65 | 20 | HP:0000036 |
| HumanPheno | Displacement of the urethral meatus | HSPG2 FAT4 WWOX BICRA GRB10 SRY CREBBP KMT2D SEC24C TP63 TRIM8 DCHS1 FGD1 CUX1 | 3.71e-04 | 397 | 65 | 14 | HP:0100627 |
| HumanPheno | Abnormal male urethral meatus morphology | HSPG2 FAT4 WWOX BICRA GRB10 SRY CREBBP KMT2D SEC24C TP63 TRIM8 DCHS1 FGD1 CUX1 | 3.91e-04 | 399 | 65 | 14 | HP:0032076 |
| HumanPheno | Choanal stenosis | 3.93e-04 | 28 | 65 | 4 | HP:0000452 | |
| HumanPheno | Cutaneous syndactyly of toes | 3.94e-04 | 50 | 65 | 5 | HP:0010621 | |
| HumanPheno | Subcortical heterotopia | 4.02e-04 | 12 | 65 | 3 | HP:0032391 | |
| HumanPheno | macules | SMARCAD1 RFX7 ADAR CREBBP KMT2D SEC24C TP63 FGFR3 PLEC PHIP SEC23B | 4.05e-04 | 262 | 65 | 11 | HP:0200031 |
| HumanPheno | Short stature | HSPG2 FAT4 KMT2B POLR1A WWOX AFF2 ANK1 BICRA TCIRG1 ESAM SRY CHD7 SIM1 ADAR CREBBP PREPL SIL1 EFTUD2 PHEX KMT2C PHLDB1 KMT2D SEC24C TP63 DCHS1 FGD1 FGFR3 PLEC CTNND2 CUX1 SEC23B | 4.13e-04 | 1407 | 65 | 31 | HP:0004322 |
| HumanPheno | Abnormal scrotum morphology | 4.14e-04 | 143 | 65 | 8 | HP:0000045 | |
| HumanPheno | Polyphagia | 4.28e-04 | 78 | 65 | 6 | HP:0002591 | |
| HumanPheno | Ureterocele | 4.51e-04 | 29 | 65 | 4 | HP:0000070 | |
| HumanPheno | Hernia of the abdominal wall | HSPG2 FAT4 HIVEP2 POLR1A CHD7 RFX7 CREBBP KMT2C KMT2D SEC24C TP63 TRIM8 FGD1 CC2D2A CTNND2 GDF11 | 4.54e-04 | 506 | 65 | 16 | HP:0004299 |
| HumanPheno | Anteverted nares | HIVEP2 POLR1A WWOX BICRA ESAM SIM1 RFX7 CREBBP EFTUD2 KMT2D TRIM8 FGD1 CC2D2A FGFR3 PLEC GDF11 PHIP | 4.57e-04 | 559 | 65 | 17 | HP:0000463 |
| HumanPheno | Upturned nose | HIVEP2 POLR1A WWOX BICRA ESAM SIM1 RFX7 CREBBP EFTUD2 KMT2D TRIM8 FGD1 CC2D2A FGFR3 PLEC GDF11 PHIP | 4.57e-04 | 559 | 65 | 17 | HP:0000427 |
| MousePheno | wide sternum | 7.93e-06 | 5 | 131 | 3 | MP:0012279 | |
| MousePheno | abnormal vertebrae morphology | HSPG2 FAT4 COL12A1 APAF1 CHD7 DELE1 SMARCAD1 CREBBP PLEKHM1 PHC2 PHEX CER1 PARP4 DCHS1 FGFR3 R3HDM1 GDF11 | 1.34e-05 | 546 | 131 | 17 | MP:0000137 |
| MousePheno | perinatal lethality | HSPG2 FAT4 COL12A1 KMT2B ANK1 APAF1 GRB10 CRPPA SMARCAD1 TNRC6C SIM1 CREBBP SIL1 EFTUD2 JARID2 KMT2C PPP2R5C TP63 SKOR2 DCHS1 FGFR3 VSX2 GDF11 CUX1 SEC23B TBX5 | 1.48e-05 | 1130 | 131 | 26 | MP:0002081 |
| MousePheno | abnormal lumbar vertebrae morphology | 1.57e-05 | 119 | 131 | 8 | MP:0003049 | |
| MousePheno | abnormal vertebral column morphology | HSPG2 FAT4 COL12A1 APAF1 CHD7 DELE1 SMARCAD1 CREBBP PLEKHM1 PHC2 PHEX CER1 PARP4 ATXN7 TP63 DCHS1 FGFR3 R3HDM1 GDF11 GAA | 4.24e-05 | 787 | 131 | 20 | MP:0004703 |
| MousePheno | small clitoris | 8.72e-05 | 2 | 131 | 2 | MP:0003530 | |
| MousePheno | clitoris hypoplasia | 8.72e-05 | 2 | 131 | 2 | MP:0009101 | |
| MousePheno | abnormal nose morphology | 1.15e-04 | 201 | 131 | 9 | MP:0002233 | |
| MousePheno | abnormal cerebellar cortex morphology | TRIM2 HIVEP2 WWOX ANK1 ADAMTS4 SPTBN2 CHD7 SIL1 ATXN7 STARD9 SKOR2 | 1.20e-04 | 300 | 131 | 11 | MP:0004097 |
| MousePheno | abnormal pectoral girdle bone morphology | HSPG2 FAT4 CHD7 SMARCAD1 CREBBP PHC2 PHEX JARID2 DCHS1 FGFR3 GDF11 | 1.23e-04 | 301 | 131 | 11 | MP:0004508 |
| MousePheno | abnormal Purkinje cell morphology | 1.28e-04 | 204 | 131 | 9 | MP:0000877 | |
| MousePheno | abnormal compact bone thickness | 1.48e-04 | 122 | 131 | 7 | MP:0000134 | |
| MousePheno | abnormal social/conspecific interaction behavior | WHRN ARHGAP32 HIVEP2 WWOX CHD8 SRR CHD7 CREBBP ADORA2A CASKIN1 CCDC157 CUX1 HR | 1.61e-04 | 421 | 131 | 13 | MP:0002557 |
| MousePheno | abnormal motor coordination/balance | WHRN ARHGAP32 TRIM2 WWOX ANK1 ADAMTS4 SPTBN2 DBNL ADCK2 CHD7 CREBBP PREPL SIL1 KMT2D PPP2R5C ATXN7 STARD9 SKOR2 CTNND2 GAA | 1.75e-04 | 873 | 131 | 20 | MP:0001516 |
| MousePheno | abnormal cerebellar layer morphology | TRIM2 HIVEP2 WWOX ANK1 ADAMTS4 SPTBN2 SIL1 ATXN7 STARD9 SKOR2 | 1.83e-04 | 263 | 131 | 10 | MP:0009956 |
| MousePheno | abnormal spine curvature | HSPG2 FAT4 COL12A1 SMARCAD1 CREBBP CER1 ATXN7 TP63 DCHS1 FGFR3 GAA | 1.99e-04 | 318 | 131 | 11 | MP:0004174 |
| MousePheno | abnormal respiratory system morphology | HSPG2 FAT4 WWOX DBNL APAF1 LAMA3 GRB10 CHD7 DOK2 TNRC6C CREBBP PHEX ADORA2A TP63 DCHS1 CC2D2A CACNA1H FGFR3 GDF11 PHIP CUX1 SEC23B | 2.10e-04 | 1027 | 131 | 22 | MP:0002132 |
| MousePheno | abnormal cartilage development | 2.14e-04 | 172 | 131 | 8 | MP:0000164 | |
| MousePheno | abnormal compact bone morphology | 2.14e-04 | 172 | 131 | 8 | MP:0003797 | |
| MousePheno | abnormal vertebrae development | 2.23e-04 | 59 | 131 | 5 | MP:0005225 | |
| MousePheno | abnormal cerebellar Purkinje cell layer | 2.26e-04 | 220 | 131 | 9 | MP:0000875 | |
| MousePheno | abnormal femur head morphology | 2.60e-04 | 3 | 131 | 2 | MP:0030788 | |
| MousePheno | abnormal skeleton development | HSPG2 FAT4 COL12A1 WWOX APAF1 ITGA10 TCIRG1 CREBBP PHEX TLE4 DCHS1 CACNA1H FGFR3 | 2.89e-04 | 447 | 131 | 13 | MP:0002113 |
| MousePheno | abnormal stomach epithelium morphology | 3.44e-04 | 36 | 131 | 4 | MP:0000471 | |
| Domain | FYrich_C | 5.54e-06 | 5 | 155 | 3 | IPR003889 | |
| Domain | FYrich_N | 5.54e-06 | 5 | 155 | 3 | IPR003888 | |
| Domain | FYRC | 5.54e-06 | 5 | 155 | 3 | SM00542 | |
| Domain | FYRN | 5.54e-06 | 5 | 155 | 3 | SM00541 | |
| Domain | FYRN | 5.54e-06 | 5 | 155 | 3 | PF05964 | |
| Domain | FYRC | 5.54e-06 | 5 | 155 | 3 | PF05965 | |
| Domain | FYRC | 5.54e-06 | 5 | 155 | 3 | PS51543 | |
| Domain | FYRN | 5.54e-06 | 5 | 155 | 3 | PS51542 | |
| Domain | GSCR1_dom | 6.84e-05 | 2 | 155 | 2 | IPR015671 | |
| Domain | GLTSCR1 | 6.84e-05 | 2 | 155 | 2 | PF15249 | |
| Domain | SNF2_N | 1.37e-04 | 32 | 155 | 4 | IPR000330 | |
| Domain | SNF2_N | 1.37e-04 | 32 | 155 | 4 | PF00176 | |
| Domain | VWF_A | 1.76e-04 | 99 | 155 | 6 | IPR002035 | |
| Domain | UBA-like | 1.90e-04 | 64 | 155 | 5 | IPR009060 | |
| Domain | Post-SET_dom | 2.90e-04 | 16 | 155 | 3 | IPR003616 | |
| Domain | PostSET | 2.90e-04 | 16 | 155 | 3 | SM00508 | |
| Domain | POST_SET | 2.90e-04 | 16 | 155 | 3 | PS50868 | |
| Domain | - | 3.75e-04 | 74 | 155 | 5 | 3.40.50.410 | |
| Domain | PHOSPHOPANTETHEINE | 6.73e-04 | 5 | 155 | 2 | PS00012 | |
| Domain | EPHD | 7.69e-04 | 22 | 155 | 3 | PS51805 | |
| Domain | - | 9.98e-04 | 24 | 155 | 3 | 3.40.20.10 | |
| Domain | ADF-H/Gelsolin-like_dom | 9.98e-04 | 24 | 155 | 3 | IPR029006 | |
| Domain | Sec23/24_helical_dom | 1.00e-03 | 6 | 155 | 2 | IPR006900 | |
| Domain | BRK | 1.00e-03 | 6 | 155 | 2 | SM00592 | |
| Domain | Sec23_24_beta_S | 1.00e-03 | 6 | 155 | 2 | IPR012990 | |
| Domain | zf-Sec23_Sec24 | 1.00e-03 | 6 | 155 | 2 | PF04810 | |
| Domain | Sec23_trunk | 1.00e-03 | 6 | 155 | 2 | PF04811 | |
| Domain | Sec23_helical | 1.00e-03 | 6 | 155 | 2 | PF04815 | |
| Domain | BRK_domain | 1.00e-03 | 6 | 155 | 2 | IPR006576 | |
| Domain | Sec23_BS | 1.00e-03 | 6 | 155 | 2 | PF08033 | |
| Domain | Sec23/24_trunk_dom | 1.00e-03 | 6 | 155 | 2 | IPR006896 | |
| Domain | Znf_Sec23_Sec24 | 1.00e-03 | 6 | 155 | 2 | IPR006895 | |
| Domain | BRK | 1.00e-03 | 6 | 155 | 2 | PF07533 | |
| Domain | - | 1.17e-03 | 95 | 155 | 5 | 2.60.120.200 | |
| Domain | VWA | 1.20e-03 | 56 | 155 | 4 | PF00092 | |
| Domain | Laminin_G | 1.37e-03 | 58 | 155 | 4 | IPR001791 | |
| Domain | CUT | 1.40e-03 | 7 | 155 | 2 | PS51042 | |
| Domain | CUT | 1.40e-03 | 7 | 155 | 2 | PF02376 | |
| Domain | CUT_dom | 1.40e-03 | 7 | 155 | 2 | IPR003350 | |
| Domain | CUT | 1.40e-03 | 7 | 155 | 2 | SM01109 | |
| Domain | VIT | 1.85e-03 | 8 | 155 | 2 | PF08487 | |
| Domain | VIT | 1.85e-03 | 8 | 155 | 2 | SM00609 | |
| Domain | LAMININ_IVA | 1.85e-03 | 8 | 155 | 2 | PS51115 | |
| Domain | Laminin_B | 1.85e-03 | 8 | 155 | 2 | PF00052 | |
| Domain | LamB | 1.85e-03 | 8 | 155 | 2 | SM00281 | |
| Domain | Laminin_IV | 1.85e-03 | 8 | 155 | 2 | IPR000034 | |
| Pubmed | RANGAP1 UBAP2 KMT2B EP400 SPTBN2 DBNL CHD8 RFX1 MIDEAS ADAR CREBBP CEP170 KMT2C FASN KMT2D LRBA SAP130 CUX1 DCP1A | 1.56e-11 | 549 | 163 | 19 | 38280479 | |
| Pubmed | HSPG2 ARHGAP32 UBAP2 KMT2B EP400 RADX BICRA CHD8 CHD7 GIGYF1 TNRC6C RFX7 RFX1 MIDEAS CREBBP MRPL2 PCF11 KMT2C C3P1 KMT2D ATXN7 TLE4 UBXN7 CPSF1 R3HDM1 SAP130 CUX1 SEC23B DCP1A | 2.67e-11 | 1429 | 163 | 29 | 35140242 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RANGAP1 KMT2B WASHC2C EP400 CHD7 SMARCAD1 RFX7 RFX1 HDAC7 PHC2 EFTUD2 PCF11 FASN KMT2D SEC24C ATXN7 TLE4 CPSF1 PLEC DCP1A | 7.57e-10 | 774 | 163 | 20 | 15302935 |
| Pubmed | WHRN WASHC2C EP400 SMURF1 GRB10 SMARCAD1 TNRC6C PHLDB1 SEC24C STARD9 ZFR2 TLE4 CACNA1H R3HDM1 PLXNB3 | 1.02e-09 | 407 | 163 | 15 | 12693553 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HSPG2 HIVEP2 KMT2B GTPBP6 EP400 BICRA GRB10 CHD8 TNRC6C HDAC7 PLEKHM1 SIL1 PHC2 KMT2C FASN PHLDB1 KMT2D CASKIN1 CPSF1 CACNA1H PLEC LRBA HR | 2.36e-09 | 1105 | 163 | 23 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FOXO1 ARHGAP32 HIVEP2 UBAP2 DBNL GRB10 GIGYF1 PLEKHG2 RFX7 HDAC7 SHKBP1 CEP170 PHLDB1 STARD9 MPHOSPH9 SSH2 PLEC R3HDM1 SEC23B DCP1A | 4.62e-09 | 861 | 163 | 20 | 36931259 |
| Pubmed | ARHGAP32 FAT4 ADCK2 CHD7 RFX1 CREBBP PREPL PARP4 PHLDB1 KMT2D GUCY1B2 ATXN7 TRIM8 TIGD5 CTNND2 MAML3 CUX1 | 9.82e-09 | 638 | 163 | 17 | 31182584 | |
| Pubmed | ARHGAP32 HIVEP2 BICRA SPTBN2 LAMA3 CHD8 NCKAP5 MIDEAS CREBBP KMT2C SIMC1 BICRAL MPHOSPH9 PLEC CUX1 | 1.11e-08 | 486 | 163 | 15 | 20936779 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EP400P1 HIVEP2 POLR1A WWOX GTPBP6 BICRA SMURF1 LAMA3 GRB10 MSH5 TNRC6C ATP10A CREBBP PLEKHM1 SIL1 SHKBP1 CEP170 KMT2C PHLDB1 ATXN7 CACNA1H LRBA SAP130 MAML3 CUX1 | 3.21e-08 | 1489 | 163 | 25 | 28611215 |
| Pubmed | 4.62e-08 | 152 | 163 | 9 | 38360978 | ||
| Pubmed | 6.11e-08 | 157 | 163 | 9 | 30186101 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | HIVEP2 KMT2B EP400 BICRA CHD8 CHD7 RFX7 MIDEAS CREBBP KMT2C KMT2D TLE4 | 1.15e-07 | 351 | 163 | 12 | 38297188 |
| Pubmed | 1.34e-07 | 83 | 163 | 7 | 28794006 | ||
| Pubmed | Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation. | 4.03e-07 | 4 | 163 | 3 | 19221051 | |
| Pubmed | 4.03e-07 | 4 | 163 | 3 | 28398509 | ||
| Pubmed | A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. | 4.03e-07 | 4 | 163 | 3 | 23129768 | |
| Pubmed | 6.11e-07 | 268 | 163 | 10 | 33640491 | ||
| Pubmed | KMT2B WWOX CHD8 CHD7 RFX1 FASN KMT2D TLE4 PLEC LRBA CUX1 DCP1A | 7.37e-07 | 418 | 163 | 12 | 34709266 | |
| Pubmed | FOXO1 TRIM2 HIVEP2 TACC2 SIM1 ONECUT1 CREBBP KMT2C TRIM8 TIGD5 VSX2 MAML3 PHIP CUX1 DCP1A | 1.40e-06 | 709 | 163 | 15 | 22988430 | |
| Pubmed | Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. | 2.00e-06 | 6 | 163 | 3 | 17021013 | |
| Pubmed | CHARGE and Kabuki syndromes: a phenotypic and molecular link. | 2.00e-06 | 6 | 163 | 3 | 24705355 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RANGAP1 UBAP2 WWOX EP400 BICRA CHD8 CHD7 RFX1 MIDEAS ADAR EFTUD2 PCF11 CEP170 SIMC1 SAP130 PHIP CUX1 | 2.77e-06 | 954 | 163 | 17 | 36373674 |
| Pubmed | 2.84e-06 | 130 | 163 | 7 | 12421765 | ||
| Pubmed | 2.95e-06 | 186 | 163 | 8 | 14744259 | ||
| Pubmed | 3.31e-06 | 133 | 163 | 7 | 15144186 | ||
| Pubmed | 3.49e-06 | 7 | 163 | 3 | 30604749 | ||
| Pubmed | 3.49e-06 | 7 | 163 | 3 | 19556342 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | CUL1 RANGAP1 CHD8 CHD7 SMARCAD1 EFTUD2 PCF11 PARP4 FASN SEC24C CPSF1 PLEC SEC23B | 4.05e-06 | 582 | 163 | 13 | 20467437 |
| Pubmed | ARHGAP32 ADAMTS4 SPTBN2 DELE1 ATP10A EFTUD2 PCF11 CEP170 PARP4 KRBA1 SSH2 MAML3 | 4.05e-06 | 493 | 163 | 12 | 15368895 | |
| Pubmed | CUL1 KMT2B EP400 BICRA CHD8 CHD7 RFX1 MIDEAS ADAR CREBBP PCF11 CEP170 KMT2C FASN KMT2D BICRAL SAP130 CUX1 | 4.72e-06 | 1103 | 163 | 18 | 34189442 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | RANGAP1 EP400 CHD8 SMARCAD1 RFX1 MIDEAS KMT2D UBXN7 SAP130 DCP1A | 5.27e-06 | 341 | 163 | 10 | 32971831 |
| Pubmed | 5.56e-06 | 8 | 163 | 3 | 22266653 | ||
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 5.56e-06 | 8 | 163 | 3 | 23130995 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 6.13e-06 | 146 | 163 | 7 | 23892456 | |
| Pubmed | 6.37e-06 | 274 | 163 | 9 | 34244482 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ARHGAP32 UBAP2 AFF2 EP400 BICRA CHD7 SMARCAD1 GUCY1B2 TP63 PLEC SAP130 | 6.48e-06 | 430 | 163 | 11 | 35044719 |
| Pubmed | 8.03e-06 | 282 | 163 | 9 | 23667531 | ||
| Pubmed | 8.32e-06 | 9 | 163 | 3 | 22665483 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | FOXO1 BMP2K GRB10 GIGYF1 MSH5 TNRC6C SHKBP1 CEP170 HROB PHLDB1 SEC24C KCTD3 MPHOSPH9 SSH2 R3HDM1 SEC23B DCP1A | 8.40e-06 | 1038 | 163 | 17 | 26673895 |
| Pubmed | DCAF8, a novel MuRF1 interaction partner, promotes muscle atrophy. | KMT2B GRB10 MSH5 PLEKHM1 PHC2 HROB TIGD5 IL4I1 SEC23B GPRIN2 | 9.31e-06 | 364 | 163 | 10 | 31391242 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | CUL1 GIGYF1 MIDEAS CREBBP PCF11 KMT2C PARP4 KMT2D MEIOC SAP130 MAML3 | 1.14e-05 | 457 | 163 | 11 | 32344865 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXO1 CUL1 RANGAP1 EP400 SMARCAD1 RFX1 ADAR CREBBP FASN KMT2D TLE4 SAP130 CUX1 GAA DCP1A | 1.36e-05 | 857 | 163 | 15 | 25609649 |
| Pubmed | Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid. | 1.40e-05 | 65 | 163 | 5 | 23319000 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RANGAP1 EP400 SPTBN2 SMURF1 CHD7 SIM1 ADAR PHC2 SHKBP1 EFTUD2 PCF11 CEP170 SEC24C KCTD3 CPSF1 PLEC SEC23B | 1.43e-05 | 1082 | 163 | 17 | 38697112 |
| Pubmed | 1.62e-05 | 11 | 163 | 3 | 37012455 | ||
| Pubmed | 1.62e-05 | 11 | 163 | 3 | 24349473 | ||
| Pubmed | PDXDC1 FAT4 AFF2 EP400 BMP2K LYSMD4 EFTUD2 PCF11 CD5 SEC24C MPHOSPH9 LRBA CUX1 SEC23B | 1.94e-05 | 777 | 163 | 14 | 35844135 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | CUL1 RANGAP1 POLR1A EP400 DBNL CHD8 CHD7 SMARCAD1 MIDEAS ADAR CREBBP EFTUD2 FASN PHLDB1 SEC24C CPSF1 PLEC PHIP DCP1A | 2.09e-05 | 1353 | 163 | 19 | 29467282 |
| Pubmed | Activator-mediated recruitment of the MLL2 methyltransferase complex to the beta-globin locus. | 2.16e-05 | 12 | 163 | 3 | 17707229 | |
| Pubmed | 2.16e-05 | 12 | 163 | 3 | 27563068 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 15987820 | ||
| Pubmed | KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis. | 2.18e-05 | 2 | 163 | 2 | 29440247 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 35640156 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 31924266 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 24603075 | ||
| Pubmed | CHD8 interacts with CHD7, a protein which is mutated in CHARGE syndrome. | 2.18e-05 | 2 | 163 | 2 | 20453063 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 28475860 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 28967912 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 10642512 | ||
| Pubmed | Giant cadherins Fat and Dachsous self-bend to organize properly spaced intercellular junctions. | 2.18e-05 | 2 | 163 | 2 | 25355906 | |
| Pubmed | A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome. | 2.18e-05 | 2 | 163 | 2 | 27999180 | |
| Pubmed | Restoration of retinal development in Vsx2 deficient mice by reduction of Gdf11 levels. | 2.18e-05 | 2 | 163 | 2 | 22183392 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 36601880 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 28483418 | ||
| Pubmed | The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape. | 2.18e-05 | 2 | 163 | 2 | 34156443 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 16219677 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 15304484 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 29797489 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 27280393 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 36869380 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 24211491 | ||
| Pubmed | Comparison of methylation episignatures in KMT2B- and KMT2D-related human disorders. | 2.18e-05 | 2 | 163 | 2 | 35506254 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 27370225 | ||
| Pubmed | Structure of the planar cell polarity cadherins Fat4 and Dachsous1. | 2.18e-05 | 2 | 163 | 2 | 36797229 | |
| Pubmed | Mammalian cadherins DCHS1-FAT4 affect functional cerebral architecture. | 2.18e-05 | 2 | 163 | 2 | 25930014 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 19517019 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 25346535 | ||
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | 2.30e-05 | 322 | 163 | 9 | 39098523 | |
| Pubmed | 2.79e-05 | 13 | 163 | 3 | 21502505 | ||
| Pubmed | 2.99e-05 | 126 | 163 | 6 | 16284245 | ||
| Pubmed | HSPG2 ARHGAP32 FAT4 KMT2B WASHC2C NOXA1 GIGYF1 PREPL TENT5B PHC2 ATXN7 R3HDM1 | 3.24e-05 | 608 | 163 | 12 | 16713569 | |
| Pubmed | 3.54e-05 | 14 | 163 | 3 | 12482968 | ||
| Pubmed | 3.54e-05 | 14 | 163 | 3 | 18173839 | ||
| Pubmed | 4.98e-05 | 43 | 163 | 4 | 33472061 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | RANGAP1 WASHC2C EP400 CHD8 TACC2 CREBBP CEP170 ATXN7 SIMC1 DCP1A | 5.05e-05 | 444 | 163 | 10 | 34795231 |
| Pubmed | ARHGAP32 RANGAP1 UBAP2 SPTBN2 CHD8 CHD7 PREPL EFTUD2 CEP170 SEC24C CASKIN1 DCHS1 SSH2 CTNND2 CUX1 | 5.17e-05 | 963 | 163 | 15 | 28671696 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ARHGAP32 RANGAP1 WASHC2C BMP2K SPTBN2 DBNL PLEKHG2 TNRC6C HROB CCDC66 MEIOC SIMC1 MPHOSPH9 PLEC | 5.32e-05 | 853 | 163 | 14 | 28718761 |
| Pubmed | 5.41e-05 | 16 | 163 | 3 | 24368734 | ||
| Pubmed | WWOX WASHC2C BMP2K DBNL CEACAM4 SMURF1 TACC2 CHD7 MSH5 KMT2C PPP2R5C SEC24C CLCNKA TLE4 PLEC DCP1A | 5.45e-05 | 1084 | 163 | 16 | 11544199 | |
| Pubmed | 5.45e-05 | 44 | 163 | 4 | 31273033 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 5.81e-05 | 363 | 163 | 9 | 14691545 | |
| Pubmed | ARHGAP32 FOXRED1 UBAP2 SPTBN2 ADAR EFTUD2 CEP170 FASN SEC24C CPSF1 PLEC | 6.28e-05 | 551 | 163 | 11 | 34728620 | |
| Pubmed | RANGAP1 POLR1A SPTBN2 CHD8 CHD7 CEP170 FASN SEC24C CPSF1 PLEC PHIP SEC23B | 6.42e-05 | 653 | 163 | 12 | 22586326 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 23603247 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 34463256 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 34510201 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 25884766 | ||
| Pubmed | Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype. | 6.53e-05 | 3 | 163 | 2 | 21139072 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 15890677 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 10852958 | ||
| Interaction | SP7 interactions | CUL1 KMT2B EP400 BICRA CHD7 RFX1 MIDEAS CREBBP PCF11 KMT2C KMT2D TLE4 CPSF1 SAP130 CUX1 | 2.31e-08 | 304 | 161 | 15 | int:SP7 |
| Interaction | FEV interactions | KMT2B EP400 BICRA CHD7 RFX1 MIDEAS CREBBP KMT2C KMT2D TLE4 CUX1 | 7.37e-07 | 203 | 161 | 11 | int:FEV |
| Interaction | ASF1A interactions | CUL1 KMT2B EP400 RADX BICRA SPTBN2 CHD8 CHD7 FASN KMT2D SAP130 CUX1 | 7.95e-07 | 249 | 161 | 12 | int:ASF1A |
| Interaction | SOX9 interactions | 1.10e-06 | 97 | 161 | 8 | int:SOX9 | |
| Interaction | HNF4A interactions | FOXO1 KMT2B EP400 BICRA CHD7 MIDEAS CREBBP KMT2C KMT2D ATXN7 SAP130 CUX1 | 2.25e-06 | 275 | 161 | 12 | int:HNF4A |
| Interaction | EN1 interactions | 2.86e-06 | 110 | 161 | 8 | int:EN1 | |
| Interaction | FOXL1 interactions | RANGAP1 CHD7 SMARCAD1 MIDEAS ADAR KMT2C FASN KMT2D TLE4 CUX1 | 4.09e-06 | 196 | 161 | 10 | int:FOXL1 |
| Interaction | TBXT interactions | 4.26e-06 | 116 | 161 | 8 | int:TBXT | |
| Interaction | GATA2 interactions | 4.68e-06 | 199 | 161 | 10 | int:GATA2 | |
| Interaction | YWHAH interactions | FOXO1 ARHGAP32 HIVEP2 UBAP2 DBNL GRB10 GIGYF1 PLEKHG2 RFX7 CREBBP HDAC7 SHKBP1 EFTUD2 CEP170 PHLDB1 STARD9 CC2D2A MPHOSPH9 SSH2 PLEC LRBA R3HDM1 SEC23B DCP1A | 7.32e-06 | 1102 | 161 | 24 | int:YWHAH |
| Interaction | FOXI1 interactions | 9.03e-06 | 92 | 161 | 7 | int:FOXI1 | |
| Interaction | STIL interactions | CUL1 ARHGAP32 WWOX WASHC2C TNRC6C SEC24C MPHOSPH9 SEC23B DCP1A | 2.27e-05 | 190 | 161 | 9 | int:STIL |
| Interaction | HNF1B interactions | 2.27e-05 | 190 | 161 | 9 | int:HNF1B | |
| Interaction | EYA4 interactions | BICRA TNRC6C RFX7 MIDEAS CREBBP HROB TRIM8 MPHOSPH9 PLEC R3HDM1 | 2.67e-05 | 243 | 161 | 10 | int:EYA4 |
| Interaction | WWTR1 interactions | CUL1 RANGAP1 UBAP2 EP400 DBNL CHD8 ADAR CREBBP CEP170 KMT2D TP63 LRBA CUX1 | 3.58e-05 | 422 | 161 | 13 | int:WWTR1 |
| Interaction | NUP35 interactions | CA9 RANGAP1 GIGYF1 MIDEAS CREBBP PCF11 KMT2C PARP4 KMT2D MEIOC SAP130 MAML3 TBX5 | 3.76e-05 | 424 | 161 | 13 | int:NUP35 |
| Interaction | CRX interactions | EP400 BICRA CHD7 DELE1 MIDEAS CREBBP KMT2C KMT2D ATXN7 UBXN7 | 3.89e-05 | 254 | 161 | 10 | int:CRX |
| Interaction | RBPJ interactions | CUL1 RANGAP1 KMT2B CHD7 SMARCAD1 ADAR CREBBP MAML3 CUX1 TBX5 | 3.89e-05 | 254 | 161 | 10 | int:RBPJ |
| Interaction | PAX6 interactions | EP400 BICRA CHD7 MIDEAS CREBBP KMT2C KMT2D TLE4 UBXN7 VSX2 SAP130 CUX1 | 3.96e-05 | 366 | 161 | 12 | int:PAX6 |
| Interaction | TRIM47 interactions | 3.97e-05 | 48 | 161 | 5 | int:TRIM47 | |
| Interaction | SMG7 interactions | CHD8 TNRC6C CREBBP PCF11 FASN KMT2D TLE4 FGFR3 R3HDM1 PHIP DCP1A | 5.33e-05 | 319 | 161 | 11 | int:SMG7 |
| Interaction | YAP1 interactions | FOXO1 RANGAP1 UBAP2 KMT2B SPTBN2 DBNL SMURF1 CHD8 RFX1 MIDEAS ADAR CREBBP CEP170 KMT2C FASN KMT2D TP63 UBXN7 PLEC SAP130 CUX1 DCP1A | 6.16e-05 | 1095 | 161 | 22 | int:YAP1 |
| Interaction | PAX7 interactions | 6.27e-05 | 124 | 161 | 7 | int:PAX7 | |
| Interaction | EGR2 interactions | 7.12e-05 | 171 | 161 | 8 | int:EGR2 | |
| Interaction | TLX1 interactions | 8.37e-05 | 175 | 161 | 8 | int:TLX1 | |
| Interaction | PAX9 interactions | 8.46e-05 | 130 | 161 | 7 | int:PAX9 | |
| Interaction | TEAD1 interactions | 8.71e-05 | 176 | 161 | 8 | int:TEAD1 | |
| Interaction | TNRC6A interactions | KMT2B GIGYF1 TNRC6C PCF11 KMT2C HROB MPHOSPH9 PHIP SEC23B DCP1A | 8.78e-05 | 280 | 161 | 10 | int:TNRC6A |
| Interaction | NFIX interactions | 9.04e-05 | 227 | 161 | 9 | int:NFIX | |
| Interaction | SLC4A3 interactions | 1.04e-04 | 12 | 161 | 3 | int:SLC4A3 | |
| Interaction | TOP3B interactions | HSPG2 HIVEP2 UBAP2 KMT2B GTPBP6 EP400 BICRA SPTBN2 GRB10 CHD8 TNRC6C HDAC7 PLEKHM1 SIL1 PHC2 KMT2C FASN PHLDB1 KMT2D CASKIN1 CPSF1 CACNA1H PLEC LRBA SEC23B HR | 1.05e-04 | 1470 | 161 | 26 | int:TOP3B |
| Interaction | PML interactions | FOXO1 CUL1 RANGAP1 KMT2B WASHC2C EP400 CHD8 TACC2 CREBBP HDAC7 CEP170 FASN ATXN7 TP63 SIMC1 SAP130 PHIP SEC23B DCP1A | 1.71e-04 | 933 | 161 | 19 | int:PML |
| Interaction | CPEB1 interactions | 1.75e-04 | 146 | 161 | 7 | int:CPEB1 | |
| Interaction | MEN1 interactions | CUL1 RANGAP1 UBAP2 KMT2B WASHC2C EP400 CHD8 SMARCAD1 RFX1 MIDEAS ADAR EFTUD2 PCF11 KMT2C KMT2D UBXN7 CPSF1 SAP130 CUX1 DCP1A | 2.12e-04 | 1029 | 161 | 20 | int:MEN1 |
| Interaction | GCM1 interactions | 2.12e-04 | 68 | 161 | 5 | int:GCM1 | |
| Interaction | YWHAQ interactions | FOXO1 ARHGAP32 HIVEP2 UBAP2 SMURF1 ADCK2 GIGYF1 RFX7 HDAC7 EFTUD2 CEP170 FASN PHLDB1 STARD9 MPHOSPH9 SSH2 PLEC LRBA R3HDM1 SEC23B DCP1A | 2.32e-04 | 1118 | 161 | 21 | int:YWHAQ |
| Interaction | TNIK interactions | ARHGAP32 TRIM2 SPTBN2 SMURF1 CHD8 EFTUD2 CEP170 SEC24C KXD1 DCHS1 CTNND2 | 2.53e-04 | 381 | 161 | 11 | int:TNIK |
| Interaction | SMAD3 interactions | FOXO1 CUL1 KMT2B WWOX SMURF1 CHD8 SRY CREBBP PHC2 PARP4 SAP130 SBK3 | 2.59e-04 | 447 | 161 | 12 | int:SMAD3 |
| Interaction | CPEB4 interactions | 2.62e-04 | 156 | 161 | 7 | int:CPEB4 | |
| Interaction | PAX8 interactions | 2.69e-04 | 111 | 161 | 6 | int:PAX8 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 7.97e-06 | 25 | 94 | 4 | 775 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 7.20e-04 | 206 | 94 | 6 | 682 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 7.25e-04 | 34 | 94 | 3 | 487 | |
| GeneFamily | Regulatory factor X family | 7.34e-04 | 8 | 94 | 2 | 1153 | |
| GeneFamily | CUT class homeoboxes and pseudogenes | 9.40e-04 | 9 | 94 | 2 | 527 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.64e-03 | 53 | 94 | 3 | 532 | |
| GeneFamily | Cadherin related | 3.46e-03 | 17 | 94 | 2 | 24 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.88e-03 | 18 | 94 | 2 | 91 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | FOXO1 CUL1 HIVEP2 CREBBP PHC2 PCF11 CEP170 JARID2 TP63 TLE4 BICRAL PHIP | 4.23e-07 | 300 | 163 | 12 | M8702 |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN | 4.76e-06 | 200 | 163 | 9 | M8997 | |
| Coexpression | GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN | 3.65e-05 | 199 | 163 | 8 | M6964 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN | 3.78e-05 | 200 | 163 | 8 | M9463 | |
| Coexpression | GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 3.78e-05 | 200 | 163 | 8 | M294 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | ARHGAP32 CHD7 PLEKHG2 PREPL PLEKHM1 CER1 CCDC66 PPP2R5C R3HCC1L KXD1 FGD1 CC2D2A FGFR3 MPHOSPH9 R3HDM1 HYI GDF11 MAML3 PHIP CUX1 | 1.33e-06 | 780 | 157 | 20 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | ARHGAP32 AFF2 PLEKHG2 PREPL CER1 CCDC66 MPHOSPH9 LRBA GDF11 MAML3 PHIP | 1.13e-05 | 291 | 157 | 11 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.91e-08 | 200 | 164 | 9 | 88d713dfc792e7609bf7ecfb28f87cb748088570 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.11e-07 | 193 | 164 | 8 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-06 | 155 | 164 | 7 | 441fcb6d05364fc6f4973f0b973f1a80b573ce1f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.48e-06 | 163 | 164 | 7 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.59e-06 | 164 | 164 | 7 | 30c3c25b05a403a509b2e755c2f0878fecb10a02 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.55e-06 | 172 | 164 | 7 | 3b9be685fcd1634498a603b692f5ac6ddd0de176 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.93e-06 | 186 | 164 | 7 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | COPD-Epithelial-ATI|COPD / Disease state, Lineage and Cell class | 5.93e-06 | 186 | 164 | 7 | df0977f6f48a2d4e11b59971f098b01204242f0f | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.93e-06 | 186 | 164 | 7 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 6.36e-06 | 188 | 164 | 7 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.06e-06 | 191 | 164 | 7 | 2b056cbe2e82e056e1f798974999378460eb1d16 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 7.30e-06 | 192 | 164 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Globus_pallidus|World / BrainAtlas - Mouse McCarroll V32 | 7.34e-06 | 126 | 164 | 6 | 44b63f945d5bedf1a2ca1810e7e100276ea9dd89 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4|lymph-node_spleen / Manually curated celltypes from each tissue | 8.92e-06 | 198 | 164 | 7 | 2cbafcb03df3c9aca68371df500d18ab8dcc416c | |
| ToppCell | medial-2-Epithelial-Alveolar_Epithelial_Type_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.22e-06 | 199 | 164 | 7 | 456460c761e26ed4b1d88d9bee4d2a7c9bd9d416 | |
| ToppCell | medial-Epithelial-Alveolar_Epithelial_Type_1-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.22e-06 | 199 | 164 | 7 | 5263338242f95c04690d0795749ccc20b0d19f7a | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.22e-06 | 199 | 164 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | medial-Epithelial-Alveolar_Epithelial_Type_1|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.22e-06 | 199 | 164 | 7 | c11365653c69a5dfb37946231f8af05149a61a71 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.53e-06 | 200 | 164 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 2.48e-05 | 156 | 164 | 6 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 2.48e-05 | 156 | 164 | 6 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.57e-05 | 157 | 164 | 6 | 8c42af7aa1f1b6f4fe2f8d00a8b4a800f121e804 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.57e-05 | 157 | 164 | 6 | ee1be3c756b72fceac6b4ccb416dd4bd031a2193 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.57e-05 | 157 | 164 | 6 | 008f938a338f43c3251dcac574f1b4f689926c71 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 157 | 164 | 6 | d8e283414a770f05d71f0455d0822e9a9660b115 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 157 | 164 | 6 | 165e98bf944572cafbc06ef43c9eab7bd6bea1c2 | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-ILC3|Liver / Manually curated celltypes from each tissue | 3.17e-05 | 163 | 164 | 6 | 7f61483eeb1fde21843c6391468e13cb0cc2a89f | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.17e-05 | 163 | 164 | 6 | 1e8730d75cccf7292010683ab4e81a69d8e3bfa9 | |
| ToppCell | T_cells-TFH-like_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.28e-05 | 164 | 164 | 6 | b10cf59f4cc37ca6cd0ecf71d7de278cc2bdd8b5 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.39e-05 | 165 | 164 | 6 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.39e-05 | 165 | 164 | 6 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.39e-05 | 165 | 164 | 6 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-05 | 166 | 164 | 6 | f742d15b02a6f651bbd00f53e3d871f40d05a03d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-05 | 166 | 164 | 6 | 0f013bb5fdb72e88c2fc73d60cd01551a2db6341 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-05 | 166 | 164 | 6 | e941df9a1091164edde3def8fc7d410186b2bd88 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-05 | 166 | 164 | 6 | aeda46bea5d8463c24a83b98b9ed92d962d733e5 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.71e-05 | 175 | 164 | 6 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 4.86e-05 | 176 | 164 | 6 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | COVID-19-kidney-CD-IC-A|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.86e-05 | 176 | 164 | 6 | 45028197364c64e93e3ffe86aff773d47a477d49 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.18e-05 | 178 | 164 | 6 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.18e-05 | 178 | 164 | 6 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | T_cells-TFH-like_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.18e-05 | 178 | 164 | 6 | e2ae43e5ec31de6197f2cbd6089f944adbf0a163 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-migDC|lymph-node_spleen / Manually curated celltypes from each tissue | 5.68e-05 | 181 | 164 | 6 | 94680f8dbdf22d83801abc0819417751d363fb12 | |
| ToppCell | COPD-Epithelial-ATI|World / Disease state, Lineage and Cell class | 5.86e-05 | 182 | 164 | 6 | e95d946a43b1579af199900bb0e3eacbb9d65300 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.22e-05 | 184 | 164 | 6 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.22e-05 | 184 | 164 | 6 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 6.41e-05 | 185 | 164 | 6 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | Control-Epithelial-ATI|World / Disease state, Lineage and Cell class | 6.41e-05 | 185 | 164 | 6 | 0563d5042bb96ecce8446fbf26d05ef7a45e23c5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.41e-05 | 185 | 164 | 6 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.61e-05 | 186 | 164 | 6 | a906020a8df6fcca474b278f746c553b177a56b4 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.61e-05 | 186 | 164 | 6 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | COPD-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 6.61e-05 | 186 | 164 | 6 | 8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d | |
| ToppCell | Control-Epithelial-ATI|Control / Disease state, Lineage and Cell class | 6.80e-05 | 187 | 164 | 6 | fdd1c57b61ca9392ac27661a82729f37593df63c | |
| ToppCell | COPD-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 6.80e-05 | 187 | 164 | 6 | 406ecd1dabb3ed8d871aef159f7bd1e383434953 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.01e-05 | 188 | 164 | 6 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.22e-05 | 189 | 164 | 6 | 70eea8c94fa56bb15bee8065de47acea156794e9 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.43e-05 | 190 | 164 | 6 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.43e-05 | 190 | 164 | 6 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.43e-05 | 190 | 164 | 6 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.43e-05 | 190 | 164 | 6 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.43e-05 | 190 | 164 | 6 | ae97df1b06bcd46c05759b53c35dc8fea97f4ac1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.65e-05 | 191 | 164 | 6 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.65e-05 | 191 | 164 | 6 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.65e-05 | 191 | 164 | 6 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.87e-05 | 192 | 164 | 6 | 7ab626a516b07d899175ff12f1c8257688324e4b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.10e-05 | 193 | 164 | 6 | 3f8280ef849d95b2fcea5e6824b95a07febc96d0 | |
| ToppCell | IPF-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 8.33e-05 | 194 | 164 | 6 | 3892b188f424ffb80f3c75a1b6709a21c1e1601d | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.57e-05 | 195 | 164 | 6 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.57e-05 | 195 | 164 | 6 | 07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.57e-05 | 195 | 164 | 6 | b65511770ed67f7447847e2187555b362988af45 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.06e-05 | 197 | 164 | 6 | 734b8db5bb4917c9ce92ed342fe6c22b64b0d3c5 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 9.06e-05 | 197 | 164 | 6 | 836dd8110d5689f944ad1d301def38c32278b5b5 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.32e-05 | 198 | 164 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.58e-05 | 199 | 164 | 6 | 9c40b3ee39860e9d8edafd007daec11abdd95435 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.58e-05 | 199 | 164 | 6 | 72b34bce8157abe389e95cd3ed8ba578dce0cbf6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.58e-05 | 199 | 164 | 6 | 236b1417ed0875e98c6ec1ec714003bfce438d65 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.58e-05 | 199 | 164 | 6 | c5c12c8288fe868322bae9d691b91fee953ceb3e | |
| ToppCell | Macroglial|World / cells hierarchy compared to all cells using T-Statistic | 9.85e-05 | 200 | 164 | 6 | e6935ad49216d2500c15c05cbc2b89402c65e838 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.85e-05 | 200 | 164 | 6 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.85e-05 | 200 | 164 | 6 | d70bad979299615fcba707ba21296020918705e6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.85e-05 | 200 | 164 | 6 | 86ec951234015ced7126b016199e5869a0f22478 | |
| ToppCell | mLN-Dendritic_cell-cDC2|Dendritic_cell / Region, Cell class and subclass | 9.85e-05 | 200 | 164 | 6 | e3f7852aaa26a9b3e626d85e40afde799e873045 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.85e-05 | 200 | 164 | 6 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.85e-05 | 200 | 164 | 6 | 8158f4eaeff945a6788c8e732b7a1b0d78052a06 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.85e-05 | 200 | 164 | 6 | 501a3b93624df463458a35d3e6648d4ccc941724 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.85e-05 | 200 | 164 | 6 | 38c21ec379005f688df33aea65237a063c476c2e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.85e-05 | 200 | 164 | 6 | d1f36a8232411933b1494168ec912fd0e5246428 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.85e-05 | 200 | 164 | 6 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 9.85e-05 | 200 | 164 | 6 | 6b7314c425f6b40f1301dd39cc02b0436e96a2ec | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.85e-05 | 200 | 164 | 6 | 140aff451cd58e1d544ee668e49e37e577f6f068 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.85e-05 | 200 | 164 | 6 | 600d56257b1b0cda8ed2fd0db92c6551711f7d6d | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.85e-05 | 200 | 164 | 6 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.85e-05 | 200 | 164 | 6 | c239e6f5d23caa9a59b83e9b352b2d6a691dcb28 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.85e-05 | 200 | 164 | 6 | 85bfa7f4dd07a4d4a88330e88f5886fd1ecfdeeb | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.85e-05 | 200 | 164 | 6 | 061ba851f941c616ddb462512e826c412881c3ce | |
| ToppCell | AT2_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.24e-04 | 131 | 164 | 5 | ff4e618bd944f852bbd34438f740187aca82460f | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-04 | 139 | 164 | 5 | 2fdc8f36510aff24abbc79ef2a842db75a85f946 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-04 | 139 | 164 | 5 | 5970a654c64e3b54f9d18c102f5b125eec892fc5 | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HG-U133A | TRIM2 AFF2 CEACAM4 LAMA3 PHEX ADORA2A CD5 FGD1 CPSF1 FGFR3 HR | 2.08e-07 | 199 | 163 | 11 | 122_UP |
| Drug | Zidovudine, AZT [30516-87-1]; Down 200; 15uM; MCF7; HT_HG-U133A | WHRN RANGAP1 HIVEP2 BICRA SMURF1 ITGA10 ADCK2 R3HCC1L TBX5 HR | 1.64e-06 | 197 | 163 | 10 | 3211_DN |
| Disease | neuroimaging measurement | PDXDC1 UBAP2 KMT2B WWOX DCDC1 GRB10 NCKAP5 TACC2 CHD7 SMARCAD1 MSH5 ITIH5 EFTUD2 TP63 TLE4 PDXDC2P CC2D2A FGFR3 SSH2 PLEC | 1.36e-06 | 1069 | 159 | 20 | EFO_0004346 |
| Disease | congenital heart disease (implicated_via_orthology) | 2.02e-06 | 69 | 159 | 6 | DOID:1682 (implicated_via_orthology) | |
| Disease | bipolar disorder | WHRN LETM2 HIVEP2 UBAP2 POLR1A BICRA SPTBN2 HDAC7 KMT2D STARD9 TLE4 TRIM8 BICRAL PLEC | 3.20e-06 | 577 | 159 | 14 | MONDO_0004985 |
| Disease | Squamous cell carcinoma of esophagus | 1.30e-05 | 95 | 159 | 6 | C0279626 | |
| Disease | Van Maldergem Wetzburger Verloes syndrome | 2.89e-05 | 2 | 159 | 2 | C1832390 | |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 2.89e-05 | 2 | 159 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | Van Maldergem syndrome | 2.89e-05 | 2 | 159 | 2 | cv:C1832390 | |
| Disease | Lambert-Eaton Myasthenic Syndrome | 2.89e-05 | 2 | 159 | 2 | C0022972 | |
| Disease | Myasthenic Syndrome | 2.89e-05 | 2 | 159 | 2 | C0549225 | |
| Disease | thanatophoric dysplasia (implicated_via_orthology) | 2.89e-05 | 2 | 159 | 2 | DOID:13481 (implicated_via_orthology) | |
| Disease | Periventricular gray matter heterotopia | 2.89e-05 | 2 | 159 | 2 | C1849173 | |
| Disease | outer ear morphology trait | 3.26e-05 | 12 | 159 | 3 | EFO_0007664 | |
| Disease | cortical thickness | HSPG2 COL12A1 KMT2B WWOX DCDC1 NUP210L SPTBN2 NCKAP5 TACC2 CHD7 SMARCAD1 PLEKHM1 ITIH5 PHLDB1 KCTD3 FGFR3 SSH2 PLEC | 3.36e-05 | 1113 | 159 | 18 | EFO_0004840 |
| Disease | Congenital small ears | 7.04e-05 | 41 | 159 | 4 | C0152423 | |
| Disease | Carcinoma, Transitional Cell | 7.04e-05 | 41 | 159 | 4 | C0007138 | |
| Disease | Osteopetrosis, Autosomal Recessive 6 | 8.63e-05 | 3 | 159 | 2 | C1969093 | |
| Disease | Osteopetrosis - intermediate type | 8.63e-05 | 3 | 159 | 2 | C0432261 | |
| Disease | Heterotopia, Periventricular, Autosomal Recessive | 8.63e-05 | 3 | 159 | 2 | C1842563 | |
| Disease | Congenital Foot Deformity | 1.72e-04 | 4 | 159 | 2 | C0016508 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.81e-04 | 152 | 159 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | brain measurement, neuroimaging measurement | PDXDC1 WWOX DCDC1 TMEM74 GRB10 NCKAP5 ITIH5 ATXN7 FGFR3 SSH2 PLEC | 2.07e-04 | 550 | 159 | 11 | EFO_0004346, EFO_0004464 |
| Disease | Diffuse Large B-Cell Lymphoma | 2.24e-04 | 55 | 159 | 4 | C0079744 | |
| Disease | red blood cell density measurement | PDXDC1 FOXO1 POLR1A WWOX WASHC2C DCDC1 ANK1 EP400 BMP2K RFX7 PHC2 CC2D2A SSH2 PLEC | 3.08e-04 | 880 | 159 | 14 | EFO_0007978 |
| Disease | cortical surface area measurement | TRIM2 WWOX DCDC1 ENPP3 CRPPA NCKAP5 CHD7 SMARCAD1 MSH5 PLEKHM1 PHC2 ITIH5 TLE4 TRIM8 FGFR3 MPHOSPH9 SSH2 CUX1 | 3.56e-04 | 1345 | 159 | 18 | EFO_0010736 |
| Disease | Sezary Syndrome | 4.08e-04 | 27 | 159 | 3 | C0036920 | |
| Disease | Human papillomavirus infectious disease (is_implicated_in) | 4.27e-04 | 6 | 159 | 2 | DOID:11166 (is_implicated_in) | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 5.95e-04 | 7 | 159 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | insulin sensitivity measurement, insulin response measurement | 7.91e-04 | 8 | 159 | 2 | EFO_0004471, EFO_0008473 | |
| Disease | Ventricular Dysfunction | 7.91e-04 | 8 | 159 | 2 | C0242973 | |
| Disease | heart function measurement | 8.13e-04 | 34 | 159 | 3 | EFO_0004311 | |
| Disease | Spinocerebellar Ataxia Type 2 | 8.13e-04 | 34 | 159 | 3 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 8.13e-04 | 34 | 159 | 3 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 8.13e-04 | 34 | 159 | 3 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 8.13e-04 | 34 | 159 | 3 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 8.13e-04 | 34 | 159 | 3 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 8.13e-04 | 34 | 159 | 3 | C0087012 | |
| Disease | Spinocerebellar Ataxia Type 4 | 8.85e-04 | 35 | 159 | 3 | C0752122 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 9.60e-04 | 139 | 159 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | insulin response measurement | 1.01e-03 | 9 | 159 | 2 | EFO_0008473 | |
| Disease | thyroxine measurement | 1.07e-03 | 83 | 159 | 4 | EFO_0005130 | |
| Disease | obesity (implicated_via_orthology) | 1.13e-03 | 215 | 159 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | glucagon-like peptide-1 measurement | 1.26e-03 | 10 | 159 | 2 | EFO_0008465 | |
| Disease | white matter microstructure measurement | 1.30e-03 | 390 | 159 | 8 | EFO_0005674 | |
| Disease | 46,XY partial gonadal dysgenesis | 1.54e-03 | 11 | 159 | 2 | C4510744 | |
| Disease | mean arterial pressure | 1.60e-03 | 499 | 159 | 9 | EFO_0006340 | |
| Disease | Craniofacial Abnormalities | 1.60e-03 | 156 | 159 | 5 | C0376634 | |
| Disease | prostate cancer (is_marker_for) | 1.60e-03 | 156 | 159 | 5 | DOID:10283 (is_marker_for) | |
| Disease | osteoarthritis, knee | 1.69e-03 | 158 | 159 | 5 | EFO_0004616 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.85e-03 | 45 | 159 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 2.05e-03 | 99 | 159 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | interleukin 6 receptor subunit alpha measurement | 2.16e-03 | 13 | 159 | 2 | EFO_0008187 | |
| Disease | Skin Abnormalities | 2.16e-03 | 13 | 159 | 2 | C0037268 | |
| Disease | complement factor H-related protein 3 measurement | 2.27e-03 | 169 | 159 | 5 | EFO_0600056 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 2.29e-03 | 102 | 159 | 4 | EFO_0004329, EFO_0004611 | |
| Disease | blood phosphate measurement | 2.58e-03 | 174 | 159 | 5 | EFO_0010972 | |
| Disease | eosinophil count | FOXO1 HIVEP2 WWOX ADAMTS4 SMURF1 GRB10 CHD7 DOK2 GIGYF1 UBASH3A CRLF2 PHC2 CD5 CACNA1H MPHOSPH9 PLEC CUX1 | 2.85e-03 | 1488 | 159 | 17 | EFO_0004842 |
| Disease | Lymphoma, Follicular, Grade 2 | 2.89e-03 | 15 | 159 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 2.89e-03 | 15 | 159 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 2.89e-03 | 15 | 159 | 2 | C1956130 | |
| Disease | Lymphoma, Large-Cell, Follicular | 2.89e-03 | 15 | 159 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 2.89e-03 | 15 | 159 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 2.89e-03 | 15 | 159 | 2 | C0079758 | |
| Disease | Intellectual Disability | 3.03e-03 | 447 | 159 | 8 | C3714756 | |
| Disease | phosphorus measurement | 3.29e-03 | 16 | 159 | 2 | EFO_0004861 | |
| Disease | Eye Abnormalities | 3.72e-03 | 17 | 159 | 2 | C0015393 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 3.72e-03 | 17 | 159 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | squamous cell carcinoma (is_implicated_in) | 4.17e-03 | 18 | 159 | 2 | DOID:1749 (is_implicated_in) | |
| Disease | disease progression measurement | 4.40e-03 | 61 | 159 | 3 | EFO_0008336 | |
| Disease | serum albumin measurement | 4.95e-03 | 592 | 159 | 9 | EFO_0004535 | |
| Disease | docosahexaenoic acid measurement | 5.02e-03 | 127 | 159 | 4 | EFO_0007761 | |
| Disease | Lymphoma, Follicular | 5.14e-03 | 20 | 159 | 2 | C0024301 | |
| Disease | Adenocarcinoma of lung (disorder) | 5.28e-03 | 206 | 159 | 5 | C0152013 | |
| Disease | lobe attachment | 5.38e-03 | 207 | 159 | 5 | EFO_0007667 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NGHLLGRQPFPNIVQ | 551 | O14727 | |
| GQTPTLGQPEARALH | 1531 | Q5SW79 | |
| IAQGAQVQLQHPGTP | 201 | Q96L91 | |
| SNAGVSRAQVPGHQP | 286 | Q7Z695 | |
| LQQPQSGGPQGHRHV | 291 | Q9HCK8 | |
| GQLHVHQNNVPGLPV | 136 | O75871 | |
| GLVPRRHAPSGNQQP | 451 | A8MYA2 | |
| GEQVSLRLNGHPPGV | 331 | P29274 | |
| PVQGQQQGPVLHSVT | 1016 | P39880 | |
| GNCNNGPVTIPQRIH | 1226 | P51816 | |
| PQNGITPLHIASRRG | 236 | P16157 | |
| LTISLGGIPPNQAHR | 4341 | Q6V0I7 | |
| GGIPPNQAHRDAQTA | 4346 | Q6V0I7 | |
| PPRLQLVAQSGGQHC | 156 | P06127 | |
| LSGQPQASHLPGQQI | 2321 | Q92793 | |
| ANSNGPFQPVVLLHI | 16 | Q13362 | |
| PGSHRTANQAQVVPG | 41 | Q96MC9 | |
| PHLVATSPAGEGQRQ | 61 | O95813 | |
| NTVLPGRPRQNSLHG | 1096 | Q9NSY1 | |
| TPQHDQIQTQPLGKG | 401 | Q9NPI6 | |
| PGRGQASSAHQPQER | 736 | Q569K6 | |
| IQERLIPGQQHPGQQ | 491 | Q9P2D1 | |
| SVPLQRTGSQHGPQN | 466 | Q9UQB3 | |
| QAGRGLPVQPHSGRS | 1466 | O60312 | |
| RNNGHSVQLTLPPGL | 196 | Q16790 | |
| PNAGVITNAPLQRHF | 126 | Q7Z5L2 | |
| GHPVSQPVLQQQGYI | 621 | Q15032 | |
| PQNGINHPGITALAQ | 216 | P46060 | |
| QQPQGPGANHDARSL | 221 | Q86UR1 | |
| SRGHTPTQPGALNQR | 646 | P98160 | |
| STPLHGQPLVVLQGN | 1021 | P98160 | |
| RPVPSGTQQRHQGSE | 1716 | P98160 | |
| PPGHSVQDGVLRIQN | 3441 | P98160 | |
| NGNITAQGPSIQPVH | 101 | Q9H2L5 | |
| SLQSVAGTEPGRHPQ | 31 | A4D126 | |
| RILQGPHANPVAVPQ | 626 | Q6NSI4 | |
| GTSVGIVQAHNPPGR | 806 | Q96JQ0 | |
| GGIVPPAAQQLHREN | 76 | Q9H4B0 | |
| AGVARSQPPVAHAGQ | 441 | Q8WXD9 | |
| SHAAPQLVLGVQGPN | 1176 | M0R2J8 | |
| RDPAGLQHVQPAGQD | 376 | O60496 | |
| QPGNTVLHPGTRLIQ | 61 | Q2VYF4 | |
| HPSPSGVGNRRLQEN | 286 | A5PL33 | |
| HVFSQGVQVNPGLIP | 2981 | Q8NEZ4 | |
| QGRHQPISVGVAPIA | 56 | Q8NG48 | |
| HQPPQAGAGDVVLLQ | 61 | Q5XG99 | |
| RAQAPNHRVQLGGLG | 796 | O75420 | |
| PQNQVTLRGRVPHLG | 1111 | Q16787 | |
| QAGQPRLTKQHFPQG | 991 | Q96JK9 | |
| QNLTHPLLLQVGEGP | 861 | Q86UX2 | |
| PNVVPVSALRGHGLQ | 431 | O43824 | |
| NPANPVQRILGGHLD | 96 | P00739 | |
| GVNQLHFIPVDLGAP | 631 | Q10570 | |
| AVLVPAGAPHQVQGL | 1116 | O43593 | |
| PRGQPNQCVGHREAS | 581 | Q8NBP7 | |
| LLPGHHPRQEQGQVT | 531 | Q9ULL4 | |
| ALPGEQQPLHALTRG | 86 | P08833 | |
| DLSHVQPGSPAINGR | 151 | Q9BQD3 | |
| EPQSPRIQNIGEQGH | 76 | Q6P996 | |
| EPQSPRIQNIGEQGH | 76 | Q6P474 | |
| HGQLLGTAREPNPSV | 261 | Q9UBC0 | |
| KQQISGIQPHGLPNA | 301 | Q99550 | |
| ISRQHEQPGQGIAPD | 1276 | P50851 | |
| AQGAQVQLQHPGTPI | 191 | Q6ZTU2 | |
| PAGILPHQQSGRSLE | 401 | Q8N3J3 | |
| QLHPGPCGLQAVSQR | 1441 | Q9UMN6 | |
| GNVRPLLHGSPVQNI | 431 | Q9UKK3 | |
| LQLPHQPLQGGDVVT | 341 | Q9HC73 | |
| GLNNSHKVQGVVPVP | 1331 | A7KAX9 | |
| NAVNVRHDQSGRGPP | 766 | O15265 | |
| GPQHQQASRFDIPLG | 1096 | O94913 | |
| GQIAPPSHLIRVEGN | 256 | Q9H3D4 | |
| PAGATHILVRQQGNP | 706 | O75173 | |
| PIVGHVQVAQVPGRG | 206 | Q5T013 | |
| GHAQQTSAVNGRPLP | 526 | Q12778 | |
| PSNVSGGLLVHRQTP | 246 | Q6AI39 | |
| SQHVIRSGDPPGNFQ | 391 | Q9P2K1 | |
| SQGLQRGFQHPSPRG | 101 | P55265 | |
| PGAPSHQAGVQIQQT | 116 | Q6ZMU1 | |
| HLTGNGRTVGLLPPQ | 2106 | Q99715 | |
| RIQPAPNNGTHGSLN | 526 | O14638 | |
| VHQSNQARGAGVPPS | 56 | Q13616 | |
| FDQNGVVGPHPLVVN | 416 | Q96CU9 | |
| THLVQQANPRGSAGP | 356 | O95390 | |
| NPGHLSQNRGISPEI | 746 | A2RUB6 | |
| LPLGIQVVAGPFNDH | 496 | Q6GMR7 | |
| PSCRLQGVPHVGANV | 156 | Q96AP7 | |
| HQQGASRPGPRDAQA | 56 | P10253 | |
| FGHQVNRQVFRQGPP | 221 | Q6PJG2 | |
| GTQSGVRPHPAQRIA | 586 | O75578 | |
| TVPLLQNGQHARSQP | 76 | Q13322 | |
| QNGQHARSQPRASGP | 81 | Q13322 | |
| LPLAQGGHRPLSRAQ | 471 | Q8WUI4 | |
| HRPILQAGLPANQTA | 251 | P22607 | |
| LGSSPVHRAQLQPGG | 146 | O60269 | |
| GGSNVHIILRPNTQP | 396 | P49327 | |
| LQAQPPGRHLFSGQL | 236 | Q6ZMB0 | |
| AAPHTGGQLIANPIL | 501 | Q9NZM4 | |
| DPSAVQGQGPGHRQR | 491 | O95180 | |
| SQAQGHPGIQTPQRS | 191 | P53992 | |
| RVLLAQPHQGGPAVA | 56 | P0C264 | |
| VQHPETVGSGPQLFQ | 401 | Q9Y597 | |
| PNHRQRPLGSSTQGL | 231 | Q8N4L8 | |
| QPPLVQQQGAGSEHI | 346 | Q9UJU6 | |
| QIHFQASLPAGPQRV | 101 | Q14154 | |
| LTFRIGNHPGVLNPS | 731 | Q5VU65 | |
| PNNTGSILRHLGAVP | 896 | Q92833 | |
| GSHPPVQGQLSLQNT | 546 | Q96RQ9 | |
| IHGPSRGNPVFQLAA | 71 | Q6QHF9 | |
| PQVLGVRIQNGRHPL | 551 | O43196 | |
| GTQDGVHVQEPRPQA | 366 | Q9Y4G2 | |
| SPGRRQAQAAPSQGH | 501 | Q9Y4G2 | |
| QQLGSNGFPLRSTHP | 681 | A2RUB1 | |
| HQAGTQLNRSPLLGP | 781 | Q9HCJ0 | |
| RQAVINGPNVHPGAS | 481 | O95602 | |
| QEGNNGPHLIVVPAS | 541 | Q9H4L7 | |
| VAHQPVVRQCGPQTG | 461 | Q99593 | |
| TPQVQRERGPQGQGH | 556 | O14513 | |
| AGAPTGTVPQQLQVH | 221 | P22670 | |
| EGSQPRPGLHQGNRI | 96 | P98174 | |
| GGVPVPIGNHAQRVA | 446 | O75343 | |
| QNVGLVAVGHSLPPS | 206 | P81133 | |
| NRHSLVGPQQLGGRP | 141 | Q8TBC3 | |
| PGSAHVQSRTPQGGL | 411 | Q8NDZ2 | |
| PGQAVPAGSHVRLNL | 81 | Q9H173 | |
| LVNQHPIGPFPRVQS | 671 | Q9P202 | |
| VHPNQEPAVIAGQGT | 151 | Q9GZT4 | |
| LGQHPQQLQPRTTIG | 3996 | Q9P2P6 | |
| PGNPAGHAEQVQARL | 251 | Q9UIL4 | |
| PHLGQILGETPQNLS | 521 | P0DKV0 | |
| APGQLRQHSPQPGVA | 211 | Q92935 | |
| VNQHNTPIPQGGRGA | 466 | Q15437 | |
| DVRGSLQTPQNRPHG | 216 | Q9HCE7 | |
| HGRGNFPTLSVQPRQ | 71 | Q96A09 | |
| QALQAEPPSRAPGHQ | 601 | P51800 | |
| NIQPSPAHETGQGIV | 511 | Q8IXK0 | |
| RQQHQSQAVTVPPPG | 441 | Q5T6F2 | |
| VQPNGSPRGVQAQLH | 306 | Q9UPR6 | |
| VHSPPNVGLRRSGQI | 681 | Q8WWQ0 | |
| GEPSQPLLGQQRLEH | 2146 | O15020 | |
| APGLAVAPRQQHGRT | 1386 | Q76I76 | |
| GPGIPRHARQINTLN | 471 | Q04727 | |
| SPPSGQAVLLRQRHG | 241 | A6NLU5 | |
| RHIQGIQPAPISTQG | 556 | Q9H0E3 | |
| LQGLPHFSVNLGVQP | 56 | Q6ZSV7 | |
| QIGAHSPPQFRVNGA | 706 | P78562 | |
| AHPLGALPVGTLINN | 181 | Q5T653 | |
| LSPRGVTSNAVHPGN | 311 | Q9NZC7 | |
| GAISPNGHRPQLRAA | 1051 | Q9Y4E1 | |
| QTPNIILDIQPGGNH | 676 | Q4J6C6 | |
| NQHPVPRGLAPNQES | 2591 | O95359 | |
| PRGLAPNQESHLQVP | 2596 | O95359 | |
| FGRLTPVSPVQHQGA | 1021 | Q2KHR2 | |
| GVHGQQRAPRDAPVA | 31 | I3L0S3 | |
| RRTPHVQAVQGPLGS | 111 | Q15149 | |
| LVNGNHTPQTATRGP | 166 | Q86UU1 | |
| PGHANLKPNQVGQVI | 31 | Q2VWA4 | |
| RGIHRVQTPQPGTND | 111 | Q8NEG5 | |
| VRTDPGTATNHQGLP | 371 | O94888 | |
| GHLPPINAASSPQQR | 181 | Q05066 | |
| TLLPEQGGSRHVQAP | 936 | Q9H7P9 | |
| QGGSRHVQAPAATPL | 941 | Q9H7P9 | |
| FPPGLLHSGNNQITA | 81 | Q96NL1 | |
| GQLQRPTGVAVHPSG | 531 | Q9C040 | |
| RQHGVPLSGPLIQAQ | 136 | Q53EQ6 | |
| VAQEPLHRGGGQIIP | 796 | Q15029 | |
| AVEGQVQLPSPHQGS | 6 | Q96HH4 | |
| PARVQEPHQNPLGSA | 2351 | P31629 | |
| STQHLVALPGGAQPV | 421 | Q9BZR9 | |
| QAPGGPHQDLRVNFV | 156 | Q13488 | |
| VHNLTPEPGNVTIRG | 51 | Q6ZRX8 | |
| PEPGNVTIRGVHNLT | 71 | Q6ZRX8 | |
| VTIRGVHNLTPEPGN | 76 | Q6ZRX8 | |
| QVPGHGPNLRLSNLT | 196 | P57075 | |
| VEQLTRLQHPGPQGQ | 611 | A6NNM8 | |
| QSVHLQPLGRASGPL | 101 | P58304 | |
| PAGPAQFIELRHNVQ | 2871 | O14686 | |
| QVAVLQQQHPGALGP | 3806 | O14686 | |
| PGHLDQVNGQVVPEA | 4396 | O14686 | |
| GRHFQTLGQPLVGTP | 96 | Q8NBZ9 |